TPST
TPST: Smith Nancy Freda discloses securities transactions
Smith Nancy Freda reported Grant or award in Tempest Therapeutics, Inc.: 25000 units of Stock Option (right to buy) (derivative), dated 2026-09-22. The full Form 4 contains 1 transaction entry.